v3.26.1
Business segment information (Details)
 12 Months Ended
Dec. 31, 2025
USD ($)
segment
item
customer
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Disclosure of operating segments [line items]      
Number of global franchise divisions | item 4    
Number of operating segments 3    
Number of reportable segments | segment 4    
Revenue $ 6,164,000,000 $ 5,810,000,000 $ 5,549,000,000
Accrual for rebates 114,000,000 106,000,000  
Revenue recognised, rebates $ 405,000,000 412,000,000  
Number of major customers | customer 0    
Established Markets      
Disclosure of operating segments [line items]      
Revenue $ 5,161,000,000 4,830,000,000 4,590,000,000
United States of America      
Disclosure of operating segments [line items]      
Revenue 3,306,000,000 3,123,000,000 2,979,000,000
United Kingdom      
Disclosure of operating segments [line items]      
Revenue 246,000,000 226,000,000 201,000,000
Emerging Markets      
Disclosure of operating segments [line items]      
Revenue 1,003,000,000 980,000,000 959,000,000
China      
Disclosure of operating segments [line items]      
Revenue 128,000,000 210,000,000 275,000,000
Advanced Wound Management      
Disclosure of operating segments [line items]      
Revenue 1,794,000,000 1,681,000,000 1,606,000,000
Advanced Wound Management | Established Markets      
Disclosure of operating segments [line items]      
Revenue 1,555,000,000 1,464,000,000 1,406,000,000
Advanced Wound Management | Emerging Markets      
Disclosure of operating segments [line items]      
Revenue 239,000,000 217,000,000 200,000,000
Orthopaedics, Sports Medicine and Ear Nose and Throat      
Disclosure of operating segments [line items]      
Revenue 4,370,000,000 4,129,000,000 3,943,000,000
Orthopaedics, Sports Medicine and Ear Nose and Throat | Established Markets      
Disclosure of operating segments [line items]      
Revenue 3,606,000,000 3,366,000,000 3,184,000,000
Orthopaedics, Sports Medicine and Ear Nose and Throat | Emerging Markets      
Disclosure of operating segments [line items]      
Revenue 764,000,000 763,000,000 759,000,000
Orthopaedics      
Disclosure of operating segments [line items]      
Revenue 2,437,000,000 2,305,000,000 2,214,000,000
Orthopaedics | Knee Implants      
Disclosure of operating segments [line items]      
Revenue 1,011,000,000 977,000,000 940,000,000
Orthopaedics | Hip Implants      
Disclosure of operating segments [line items]      
Revenue 641,000,000 619,000,000 599,000,000
Orthopaedics | Other Reconstruction      
Disclosure of operating segments [line items]      
Revenue 136,000,000 101,000,000 111,000,000
Orthopaedics | Trauma & Extremities      
Disclosure of operating segments [line items]      
Revenue 649,000,000 608,000,000 564,000,000
Sports Medicine & ENT      
Disclosure of operating segments [line items]      
Revenue 1,934,000,000 1,824,000,000 1,729,000,000
Sports Medicine & ENT | Sports Medicine Joint Repair      
Disclosure of operating segments [line items]      
Revenue 1,067,000,000 982,000,000 945,000,000
Sports Medicine & ENT | Arthroscopic Enabling Technologies      
Disclosure of operating segments [line items]      
Revenue 647,000,000 632,000,000 588,000,000
Sports Medicine & ENT | ENT (Ear, Nose and Throat)      
Disclosure of operating segments [line items]      
Revenue 220,000,000 210,000,000 196,000,000
Advanced Wound Management      
Disclosure of operating segments [line items]      
Revenue 1,793,000,000 1,681,000,000 1,606,000,000
Advanced Wound Management | Advanced Wound Care      
Disclosure of operating segments [line items]      
Revenue 766,000,000 735,000,000 725,000,000
Advanced Wound Management | Advanced Wound Bioactives      
Disclosure of operating segments [line items]      
Revenue 621,000,000 581,000,000 553,000,000
Advanced Wound Management | Advanced Wound Devices      
Disclosure of operating segments [line items]      
Revenue $ 406,000,000 $ 365,000,000 $ 328,000,000